Abstract
A long-standing mystery shrouds the mechanism by which catalytically repressed receptor tyrosine kinase domains accomplish transphosphorylation of activation loop (A-loop) tyrosines. Here we show that this reaction proceeds via an asymmetric complex that is thermodynamically disadvantaged because of an electrostatic repulsion between enzyme and substrate kinases. Under physiological conditions, the energetic gain resulting from ligand-induced dimerization of extracellular domains overcomes this opposing clash, stabilizing the A-loop-transphosphorylating dimer. A unique pathogenic fibroblast growth factor receptor gain-of-function mutation promotes formation of the complex responsible for phosphorylation of A-loop tyrosines by eliminating this repulsive force. We show that asymmetric complex formation induces a more phosphorylatable A-loop conformation in the substrate kinase, which in turn promotes the active state of the enzyme kinase. This explains how quantitative differences in the stability of ligand-induced extracellular dimerization promotes formation of the intracellular A-loop-transphosphorylating asymmetric complex to varying extents, thereby modulating intracellular kinase activity and signaling intensity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Journal of Translational Medicine Open Access 10 February 2023
-
Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
Journal of Experimental & Clinical Cancer Research Open Access 03 November 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout






Data availability
Atomic coordinates and structure factors of the FGFR3R669E asymmetric complex have been deposited in the Protein Data Bank under accession 6PNX. Raw mass spectrometry files and Mascot generic format files have been deposited in the MassIVE database under accession MSV000084018. All other data generated or analyzed during this study are included in this published article and its associated Supplementary Information.
References
Hunter, T. Signaling–2000 and beyond. Cell 100, 113–127 (2000).
Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134 (2010).
Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355–365 (2001).
Hubbard, S. R. Autoinhibitory mechanisms in receptor tyrosine kinases. Front Biosci. 7, d330–d340 (2002).
Hubbard, S. R. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5, 464–471 (2004).
Schlessinger, J. Signal transduction. Autoinhibition control. Science 300, 750–752 (2003).
Wybenga-Groot, L. E. et al. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106, 745–757 (2001).
Hubbard, S. R. & Miller, W. T. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr. Opin. Cell Biol. 19, 117–123 (2007).
Zhang, X., Gureasko, J., Shen, K., Cole, P. A. & Kuriyan, J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137–1149 (2006).
Kovacs, E., Zorn, J. A., Huang, Y., Barros, T. & Kuriyan, J. A structural perspective on the regulation of the epidermal growth factor receptor. Annu. Rev. Biochem. 84, 739–764 (2015).
Jura, N. et al. Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol. Cell 42, 9–22 (2011).
Nolen, B., Taylor, S. & Ghosh, G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15, 661–675 (2004).
Pellicena, P. & Kuriyan, J. Protein–protein interactions in the allosteric regulation of protein kinases. Curr. Opin. Struct. Biol. 16, 702–709 (2006).
Boggon, T. J. & Eck, M. J. Structure and regulation of Src family kinases. Oncogene 23, 7918–7927 (2004).
Binns, K. L., Taylor, P. P., Sicheri, F., Pawson, T. & Holland, S. J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 20, 4791–4805 (2000).
Furdui, C. M., Lew, E. D., Schlessinger, J. & Anderson, K. S. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 21, 711–717 (2006).
Wu, J. et al. Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor. EMBO J. 27, 1985–1994 (2008).
Kan, S. H. et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am. J. Hum. Genet. 70, 472–486 (2002).
McDonell, L. M., Kernohan, K. D., Boycott, K. M. & Sawyer, S. L. Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin. Hum. Mol. Genet. 24, R60–R66 (2015).
Wilkie, A. O. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16, 187–203 (2005).
Chen, H. et al. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol. Cell 27, 717–730 (2007).
Chen, H. et al. Elucidation of a four-site allosteric network in fibroblast growth factor receptor tyrosine kinases. Elife 6, e21137 (2017).
Rosen, M. K. et al. Selective methyl group protonation of perdeuterated proteins. J. Mol. Biol. 263, 627–636 (1996).
Pervushin, K., Riek, R., Wider, G. & Wuthrich, K. Attenuated T2 relaxation by mutual cancellation of dipole–dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl Acad. Sci. USA 94, 12366–12371 (1997).
Mittermaier, A. & Meneses, E. Analyzing protein–ligand interactions by dynamic NMR spectroscopy. Methods Mol. Biol. 1008, 243–266 (2013).
Mittermaier, A. K. & Kay, L. E. Observing biological dynamics at atomic resolution using NMR. Trends Biochem. Sci. 34, 601–611 (2009).
Chen, H. et al. Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations. Cell Rep. 4, 376–384 (2013).
Huang, Z. et al. Structural mimicry of A-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation. Structure 21, 1889–1896 (2013).
Korzhnev, D. M., Kloiber, K., Kanelis, V., Tugarinov, V. & Kay, L. E. Probing slow dynamics in high molecular weight proteins by methyl-TROSY NMR spectroscopy: application to a 723-residue enzyme. J. Am. Chem. Soc. 126, 3964–3973 (2004).
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D. Biol. Crystallogr. 67, 235–242 (2011).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213–221 (2010).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126–2132 (2004).
Songyang, Z. et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373, 536–539 (1995).
Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896–1906 (2007).
Byron, S. A. et al. The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. Neoplasia 15, 975–988 (2013).
Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713 (2015).
Meagher, K. L., Redman, L. T. & Carlson, H. A. Development of polyphosphate parameters for use with the AMBER force field. J. Comput. Chem. 24, 1016–1025 (2003).
Allner, O., Nilsson, L. & Villa, A. Magnesium ion–water coordination and exchange in biomolecular simulations. J. Chem. Theory Comput. 8, 1493–1502 (2012).
Webb, B. & Sali, A. Protein structure modeling with MODELLER. Curr. Protoc. Bioinformatics 54, 5.6.1–5.6.37 (2017).
Bae, J. H. et al. Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells. Proc. Natl Acad. Sci. USA 107, 2866–2871 (2010).
Salomon-Ferrer, R., Gotz, A. W., Poole, D., Le Grand, S. & Walker, R. C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. explicit solvent particle mesh ewald. J. Chem. Theory Comput. 9, 3878–3888 (2013).
Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
Carver, J. P. & Richards, R. E. General 2-site solution for chemical exchange produced dependence of T2 upon Carr–Purcell pulse separation. J. Magn. Reson. 6, 89–105 (1972).
Luz, Z. & Meiboom, S. Nuclear magnetic resonance study of the protolysis of trimethylammonium ion in aqueous solution-order of the reaction with respect to solvent. J. Chem. Phys. 39, 366–370 (1963).
Acknowledgements
The authors are indebted to N. Cowan for critically reading and editing the manuscript. This work was supported by National Institute of Dental and Craniofacial Research (NIDCR) grant R01 DE13686 (to M.M.), National Institute of General Medical Sciences (NIGMS) grant R01 GM117118 (to N.J.T.), NIGMS grant R35 GM127040 (to Y.Z.), National Institute of Neurological Disorders and Stroke (NINDS) grant P30 NS050276 and Shared Instrumentation Grant RR027990 (to T.A.N.), China Scholarship Council (CSC) and China Association for Science and Technology (CAST) (to L.C.), National Cancer Institute (NCI) predoctoral grant F99CA212474 (to W.M.M.) and the Natural Science Foundation of China (NSFC) grant 81930108 (to G.L.). An NMR cryoprobe at New York University was supported by an NIH S10 grant (OD016343). Data collection at the New York Structural Biology Center was made possible by a grant from NYSTAR. Computing resources were provided by New York University-ITS. We dedicate this work to the memory of J.M., who died suddenly before submission.
Author information
Authors and Affiliations
Contributions
H.C. purified and crystallized FGFR3KR669E, and contributed to the initial analysis of the crystal structure. L.C. expressed and purified all structure-based FGFRK proteins, established stable cell lines, generated cell-based and kinase assay data (Fig. 1, 4 and 6 and Supplementary Figs. 2, 8, 9 and 14–16), prepared the structural figures and participated in the design of experiments and in editing and revising the manuscript. W.M.M. expressed and purified all FGFR2K samples for NMR studies, acquired and interpreted the NMR data (Figs. 3 and 6, and Supplementary Figs. 5, 7 and 10–12) and participated in editing and revising the manuscript. G.S. and D.J.K. provided the catalytic turnover rates data (Fig. 1a and Supplementary Fig. 1). T.A.N. and H.E.-B. generated and interpreted LC–MS data. G.L. and X.L. contributed to manuscript revision. J.M. and L.F. engineered bacterial and lentiviral expression constructs. J.K. and Y.Z. provided the molecular dynamics simulation data (Supplementary Fig. 6). N.J.T. directed the NMR studies, interpreted NMR datasets, and participated in writing the manuscript. M.M. conceived and directed the project, solved, refined, analyzed and interpreted the crystal structure of the FGFR3KR669E asymmetric complex and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors have no conflicting interest to report
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Tables 1–3 and Supplementary Figs. 1–16
Rights and permissions
About this article
Cite this article
Chen, L., Marsiglia, W.M., Chen, H. et al. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Nat Chem Biol 16, 267–277 (2020). https://doi.org/10.1038/s41589-019-0455-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-019-0455-7
This article is cited by
-
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Journal of Translational Medicine (2023)
-
Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
Journal of Experimental & Clinical Cancer Research (2021)
-
Fibroblast growth factor signalling in osteoarthritis and cartilage repair
Nature Reviews Rheumatology (2020)